Emerging Pharmaceutical Markets Argentina and Mexico

Publication Date	March 2008
Publisher	Datamonitor
Product Type	Report
Pages	106
ISBN Number	not applicable
Product Code	DAT10942

Price

£3,800.00
approximately: $7,100 | €4,820

PDF

PRINT £3,850 ($7,194 | €4,883)

Order above formats by FAX

Summary

Introduction

Latin American countries have attracted a lot of attention recently. With their economies currently stable, their geographic location and low-cost is ideal for investors. In addition, having such a high and varied population eases recruitment for clinical trials, and the demographics show there is a very high need for pharmaceuticals.

Scope

Overview of the key trends driving the pharmaceutical market growth Analysis of key healthcare system characteristics impacting the pharmaceutical market Analysis of pharmaceutical market dynamics in Argentina and Mexico Overview of key pharmaceutical players in Argentina and Mexico

Highlights

Although both the Argentinean and the Mexican markets have been growing, their growth is attributed to different reasons. The Argentinean pharmaceutical market has been growing mainly based on growing sales volume, while growth of the Mexican market is mainly driven by growing prices. The Mexican market is dominated by foreign companies with few domestic players. The Argentinean market is dominated by domestic branded generics firms, due to the economic crisis which led to many foreign companies to sell their plants in Argentina, thus allowing the domestic firms to gain over their market share. Sales of pharmaceutical categories in both countries are very similar to the West thus opening growth opportunities for foreign companies. However, sales of oncology drugs are low in both countries; and Mexico has higher sales of anti-infective drugs indicating that these markets still have scope for further development and growth.

Reasons to Purchase

Identify the healthcare needs in Argentina and Mexico Understand the barriers and drivers for entering these markets Gain insight into pharmaceutical dynamics of Argentina and Mexico.

Content

Chapter 1 Executive Summary
- Scope of the report
- Key findings
- Argentina
- Mexico
- IMS caveat
Chapter 2 The Pharmaceutical Market in Argentina
- Argentina has stable macroeconomic factors, some of which must be strengthened
- A growing pharmaceutical market dominated by branded generics
- Demographic trends in Argentina
- Disease burden in Argentina
- Socioeconomic environment in Argentina
- Political climate in Argentina - stable
- GDP has been growing after the economic crisis of 2001
- Regional differences - the fight for equality continues
- Mercosur established free trade between the countries involved
- Corporate environment in Argentina
- Foreign direct investment in Argentina is modest
- Taxation system in Argentina
- The healthcare system in Argentina
- Healthcare expenditure in Argentina is high
- The public sector is decentralized
- Social health insurance system is fragmented
- The private sector covers a minority of the population
- The hospital capacity within the public sector has declined while the private sector has been growing
- Regulatory issues in Argentina
- IP protection has improved but is still inadequate
- A significant effort has been made to reduce the patent backlog in Argentina
- Registration of drugs in Argentina is a straight forward procedure
- Advertising of pharmaceuticals is strictly controlled
- Import of pharmaceuticals has been facilitated by Mercosur agreement
- Drug counterfeiting has been reduced by a number of measures
- Pricing and reimbursement of pharmaceuticals in Argentina
- Pricing of pharmaceuticals in Argentina
- The Generics Law, resulted in lower prices and increased access to pharmaceuticals
- Antiretroviral therapy prices were decreased
- Reimbursement of pharmaceuticals in Argentina
- Remediar program, introduced in 2002, increased drug access to the poor
- Pharmaceutical market dynamics in Argentina
- Branded generics dominate the Argentinean market
- Top three distributors dominate while retail pharmacy chains are expanding
- Top manufacturers on the Argentinean retail market
- Top ATC groups by sales value on the Argentinean retail market
- Top brands on the Argentinean retail market
- Import and export of pharmaceuticals - demand for foreign drugs remains high
- Major foreign pharmaceutical companies in Argentina
- Pfizer
- Bayer
- Roche
- Major domestic pharmaceutical companies in Argentina
- Roemmers
- Bag - collaboration and geographical expansion are driving growth
- Phoenix
- Clinical trials in Argentina - an underused opportunity
Chapter 3 The Pharmaceutical Market in Mexico
- Growth of the Mexican economy and strengthened intellectual property rights are boosting pharma industry
- The Mexican pharmaceutical market is dominated by foreign companies and is attracting a lot of clinical research
- Demographic trends in Mexico
- Disease burden in Mexico
- Socioeconomic environment in Mexico
- Political climate in Mexico
- GDP has increased since the introduction of NAFTA
- Regional differences - some rural areas are in extreme poverty
- NAFTA eliminated tariffs between the US, Canada and Mexico, and boosted the Mexican economy
- Corporate environment in Mexico
- Taxation system in Mexico
- Foreign direct investment in Mexico was boosted by NAFTA agreement
- The healthcare system in Mexico
- Healthcare system reforms in Mexico - the national health system aims to provide choice of healthcare provider
- Healthcare expenditure in Mexico is low
- The social security sector
- Governmental services headed by the Ministry of Health are designed to offer coverage to the poor and uninsured
- Only a small proportion of the population has private health insurance
- Regulatory issues in Mexico
- Intellectual property (IP) protection has significantly improved
- Registration of drugs in Mexico is simple
- Physicians play an important role in drug choices
- Import of pharmaceuticals in Mexico is facilitated by NAFTA
- Counterfeit drugs are a persistent problem in Mexico
- Pricing and reimbursement of pharmaceuticals in Mexico
- Pricing of pharmaceuticals in Mexico
- Reimbursement in Mexico
- Pharmaceutical market dynamics in Mexico
- Mexico classifies generics into three segments
- Market growth is driven mainly by growing preference and demand for high-value products and not by volume growth
- Distribution of pharmaceuticals in Mexico is dominated by two distributors
- Pharmacies selling cheap pharmaceuticals are very popular in Mexico
- Top pharmaceutical companies in Mexico-multinationals dominate
- Top ATC groups by sales value on the Mexican retail market
- Top brands on the Mexican retail market
- Import and export of pharmaceuticals have increased since NAFTA came into place
- Major foreign pharmaceutical companies in Mexico
- Sanofi-Aventis
- Pfizer
- AstraZeneca
- Major domestic pharmaceutical companies in Mexico
- Senosiain
- Clinical trials in Mexico - an attractive opportunity for US companies
Chapter 4 Bibliography
- Publications and online articles
- Datamonitor resources
- Glossary of Terms
List of Tables
- Table 1: Demographic indicators for Argentina, 2005
- Table 2: Average annual growth rate of GDP and exports in Argentina, 1998-2010 (%),
- Table 3: Key economic indicators for Argentina, 1986-2006
- Table 4: Health expenditure indicators in Argentina, 2004
- Table 5: Density of healthcare workers and hospital capacity in Argentina, 1998
- Table 6: Argentina - Growth of pharmaceutical market in terms of sales volume, 2003-06
- Table 7: Argentina - Average cost of unit sold, 2003-06
- Table 8: Branded generics dominate the Argentinean pharmaceutical market, 2006
- Table 9: Top 15 drug manufacturers in Argentina, 2006
- Table 10: Market segmentation in Argentina according to ATC groups, 2006
- Table 11: Top 15 brands in Argentina, 2006
- Table 12: Key demographic indicators for Mexico, 2005
- Table 13: Mexico -average annual growth rates of GDP and exports (%), 1986-2010
- Table 14: Key economic indicators for Mexico, 1986-2006
- Table 15: Health expenditure indicators in Mexico, 2004
- Table 16: Growth of the Mexican market in terms of sales volume, 2003-06
- Table 17: Average cost of unit sold, 2003-06
- Table 18: Top 15 drug manufacturers in Mexico in 2006
- Table 19: Growth of ATC group split in the Mexican market, 2006
- Table 20: Top 15 brands in 2006 in Mexico
List of Figures
- Figure 1: Key macroeconomic factors and healthcare system characteristics impacting the pharmaceutical industry in Argentina, 2008
- Figure 2: Pharmaceutical market dynamics in Argentina, 2008
- Figure 3: Structure of health system financing and provision in Argentina
- Figure 4: The size of the Argentinean retail pharmaceutical market, 2002-06
- Figure 5: Sales growth and CAGR for the top ATC groups in Argentina
- Figure 6: The relative market share for each ATC group in Argentina is very similar to the six major markets
- Figure 7: Clinical trial protocols assessed and approved, 1994-2006
- Figure 8: Multinational pharmaceutical companies sponsor the majority of clinical research in Argentina
- Figure 9: Advantages and disadvantages of carrying out clinical trials in Argentina
- Figure 10: Key macroeconomic factors and healthcare system characteristics impacting the pharmaceutical industry in Mexico
- Figure 11: Pharmaceutical market dynamics in Mexico
- Figure 12: The three pricing regulations in Mexico
- Figure 13: Decision process for listing pharmaceuticals on the Basic Formulary and the Catalogue of Inputs
- Figure 14: The size of the Mexican retail pharmaceutical market, 2002-06
- Figure 15: Sales growth and CAGR for the top ATC groups in Mexico, 2006
- Figure 16: The relative market shares of each ATC groups are very similar between Mexico and the six major markets
- Figure 17: Advantages and disadvantages of carrying out clinical trials in Mexico